Anastasiadou, C.; Kastora, S.; Kapelouzou, A.; Papapetrou, A.; Megalopoulos, A.; Kostomitsopoulos, N.; Paronis, E.; Lazaris, A.; Geroulakos, G.; Liapis, C.;
et al. Effect of Cilostazol in the Expression of Biomarkers and Neurological Outcome Following Experimentally Induced Cerebrovascular Accident—Experimental Protocol. Neurol. Int. 2025, 17, 126.
https://doi.org/10.3390/neurolint17080126
AMA Style
Anastasiadou C, Kastora S, Kapelouzou A, Papapetrou A, Megalopoulos A, Kostomitsopoulos N, Paronis E, Lazaris A, Geroulakos G, Liapis C,
et al. Effect of Cilostazol in the Expression of Biomarkers and Neurological Outcome Following Experimentally Induced Cerebrovascular Accident—Experimental Protocol. Neurology International. 2025; 17(8):126.
https://doi.org/10.3390/neurolint17080126
Chicago/Turabian Style
Anastasiadou, Christiana, Stavroula Kastora, Alkistis Kapelouzou, Anastasios Papapetrou, Angelos Megalopoulos, Nikolaos Kostomitsopoulos, Efthymios Paronis, Andreas Lazaris, George Geroulakos, Christos Liapis,
and et al. 2025. "Effect of Cilostazol in the Expression of Biomarkers and Neurological Outcome Following Experimentally Induced Cerebrovascular Accident—Experimental Protocol" Neurology International 17, no. 8: 126.
https://doi.org/10.3390/neurolint17080126
APA Style
Anastasiadou, C., Kastora, S., Kapelouzou, A., Papapetrou, A., Megalopoulos, A., Kostomitsopoulos, N., Paronis, E., Lazaris, A., Geroulakos, G., Liapis, C., Saratzis, N., & Kakisis, J.
(2025). Effect of Cilostazol in the Expression of Biomarkers and Neurological Outcome Following Experimentally Induced Cerebrovascular Accident—Experimental Protocol. Neurology International, 17(8), 126.
https://doi.org/10.3390/neurolint17080126